Page last updated: 2024-11-13
cycloxaprid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
cycloxaprid: a neonicotinoid insecticide; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 58496250 |
SCHEMBL ID | 888470 |
MeSH ID | M0587655 |
Synonyms (6)
Synonym |
---|
SCHEMBL888470 |
1-((6-chloropyridin-3-yl)methyl)-9-nitro-2,3,5,6,7,8-hexahydro -1h-5,8-epoxyimidazo[1,2-a]azepine |
NDHXMRFNYMNBKO-UHFFFAOYSA-N |
1-((6-chloropyridin-3-yl)methyl)-9-nitro-2,3,5,6,7,8-hexahydro-1h-5,8-epoxyimidazo[1,2-a]azepine |
cycloxaprid |
1203791-41-6 |
Research Excerpts
Overview
Cycloxaprid (CYC) is a promising neonicotinoid due to its insecticidal effectiveness and low cross resistance, but little is known about its fate in soils. It is currently under development in China for agricultural pest control.
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
"82, which suggested CYC immobilization in the soil resulted in its bioavailability being reduced which enhanced its degradation." | ( Bioavailability and release of nonextractable (bound) residues of chiral cycloxaprid using geophagous earthworm Metaphire guillelmi in rice paddy soil. Li, C; Li, Z; Liu, X; Shao, X; Xu, X; Ye, Q; Zhang, H, 2015) | 0.65 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (32)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 20 (62.50) | 24.3611 |
2020's | 12 (37.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.76
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.76) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (3.13%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 31 (96.88%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |